SCHEMBL24200041

SCHEMBL24200041

OC1CCCN(Cc2ccccc2)CCC1

nearest known ligand 0.81

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.81
SIGMAR1 Q99720 3/20 0.61
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C19 P33261 1/20 0.60
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
ACHE P22303 1/20 0.58
CCR3 P51677 1/20 0.56
MEN1 O00255 1/20 0.54
TSHR P16473 1/20 0.54
KMT2A Q03164 1/20 0.54
FUCA1 P04066 2/20 0.53
DRD2 P14416 1/20 0.53
DRD4 P21917 1/20 0.53
DRD3 P35462 1/20 0.53
CXCR4 P61073 1/20 0.53
MC4R P32245 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24200039 0.96 ALDH1A1 (0.76) ALDH1A1SIGMAR1CYP1A2CYP3A4CYP2D6
SCHEMBL5401732 0.96 ALDH1A1 (0.76) ALDH1A1SIGMAR1CYP1A2CYP3A4CYP2D6
SCHEMBL22432783 0.96 ALDH1A1 (0.76) ALDH1A1SIGMAR1CYP1A2CYP3A4CYP2D6
SCHEMBL1552926 0.89 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5205368 0.89 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1787570 0.89 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL11398679 0.89 ALDH1A1 (0.66) ALDH1A1SIGMAR1CYP1A2CYP3A4CYP2D6
SCHEMBL266138 0.89 NPC1 (0.71) ALDH1A1SIGMAR1NPC1RAB9AACHE
Methane SCHEMBL7287824 0.88 ALDH1A1 (0.97) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL5343928 0.88 ALDH1A1 (0.97) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127206-A1 METHOD FOR INTRODUCING DEUTERATED LOWER ALKYL INTO AMINE MOIETY OF COMPOUND CONTAINING SECONDARY AMINE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-04-28 US disclosed
EP-3939954-A1 METHOD FOR INTRODUCING DEUTERATED LOWER ALKYL INTO AMINE MOIETY OF COMPOUND CONTAINING SECONDARY AMINE Otsuka Pharmaceutical Co., Ltd. (JP) 2022-01-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127206-A1 METHOD FOR INTRODUCING DEUTERATED LOWER ALKYL INTO AMINE MOIETY OF COMPOUND CONTAINING SECONDARY AMINE MGMT, FANCD2, ADAR ALDH1A1 2354/4885SIGMAR1 2839/4885CYP1A2 1194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.